Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a Ras-independent pathway

Journal of Experimental Medicine

Volumn 187, Issue 2, 1998, Pages 237-244

  Kashiwada, Masaki ^a   Shirakata, Yumiko ^a   Inoue, Jun Ichiro ^b   Nakano, Hiroyasu ^c   Okazaki, Kenji ^d   Okumura, Ko ^c   Yamamoto, Tadashi ^b   Nagaoka, Hitoshi ^a   Takemori, Toshitada ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; PROTEIN KINASE; RAS PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CELL LINE; ENZYME ACTIVATION; HUMANS; KIDNEY; NF-KAPPA B; PROTEINS; RAS PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 0031975588     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.2.237     Document Type: Article

References (60)

1. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
2. Rothe, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:681-692.
3. Hu, H.M., K. O'Rourke, M.S. Boguski, and V.M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
4. Sato, T., S. Irie, and J.C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:113-118.
5. Cheng, G., A.M. Cleary, Z.S. Ye, D.I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1494-1498.
6. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1424-1427.
7. Cheng, G., and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-kappaB activation. Genes Dev. 10:963-973.
8. Ishida, T.K., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J. Inoue. 1996. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA. 93: 9437-9442.
9. Ishida, T., S.I. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745-28748.
10. Hanissian, S.H., and R.S. Geha. 1997. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity. 6:379-387.
11. Lalmanach, G.A., T.C. Chiles, D.C. Parker, and T.L. Rothstein. 1993. T cell-dependent induction of NF-kappa B in B cells. J. Exp. Med. 177:1215-1219.
12. Ren, C.L., T. Morio, S.M. Fu, and R.S. Geha. 1994. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2. J. Exp. Med. 179:673-680.
13. Faris, M., F. Gaskin, J.T. Parsons, and S.M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179:1923-1931.
14. Berberich, I., G.L. Shu, and E.A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 153:4357-4366.
15. Sakata, N., H.R. Patel, N. Terada, A. Aruffo, G.L. Johnson, and E.W. Gelfand. 1995. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J. Biol. Chem. 270:30823-30828.
16. Berberich, I., G. Shu, F. Siebelt, J.R. Woodgett, J.M. Kyriakis, and E.A. Clark. 1996. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO (Eur. Mol. Biol. Organ.) J. 15:92-101.
17. Kashiwada, M., Y. Kaneko, H. Yagita, K. Okumura, and T. Takemori. 1996. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells. Eur. J. Immunol. 26:1451-1458.
18. Li, Y.Y., M. Baccam, S.B. Waters, J.E. Pessin, G.A. Bishop, and G.A. Koretzky. 1996. CD40 ligation results in protein kinase C-independent actuation of ERK and JNK in resting murine splenic B cells. J. Immunol. 157:1440-1447.
19. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt. N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:990-993.
20. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
21. Korthauer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcolm, A.C., Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 361:539-541.
22. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 361:541-543.
23. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R.S. Rosen, T. Chatila, S.M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
24. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani, 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
25. Castigli, E., F.W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A.K. Bhan, and R.S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91: 12135-12139.
26. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand (published erratum 1:613). Immunity. 1:423-431.
27. Clark, E.A., and J.A. Ledbetter. 1994. How B and T cells talk to each other. Nature. 367:425-128.
28. Hsu, H., H.B. Shu, M.G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
29. Gedrich, R.W., M.C. Gilfillan, C.S. Duckett, D.J. Van Dongen, and C.B. Thompson. 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:12852-12858.
30. Nakano, H., H. Oshima, W. Chung, A.L. Williams, C.F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem. 271:14661-14664.
31. Lee, S.Y., S.Y. Lee, G. Kandala, M.L. Liou, H.C. Liou, and Y. Choi. 1996. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc. Natl. Acad. Sci. USA. 93:9699-9703.
32. Aizawa, S., H. Nakano, T. Ishida, R. Hone, M. Nagai, K. Ito, H. Yagita, K. Okumura, J. Inoue, and T. Watanabe. 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J. Biol. Chem. 272:2042-2045.
33. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature. 383:443-446.
34. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:565-576.
35. Natoli, G., A. Costanzo, A. Ianni, D.J. Templeton, J.R. Woodgett, C. Balsano, and M. Levrero. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 275:200-203.
36. Reinhard, C., B. Shamoon, V. Shyamala, and L.T. Williams. 1997. Tumor necrosis factor α-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO (Eur. Mol. Biol. Organ.) J. 16:1080-1092.
37. Schaap, D., J. van der Wal, L.R. Howe, C.J. Marshall, and W.J. van Blitterswijk. 1993. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268: 20232-20236.
38. Feig, L.A., and G.M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
39. Okazaki, K., and N. Sagata. 1995. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Oncogene. 10:1149-1157.
40. Seth, A., E. Alvarez, S. Gupta, and R.J. Davis. 1991. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266:23521-23524.
41. Seth, A., F.A. Gonzalez, S. Gupta, D.L. Raden, and R.J. Davis. 1992. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267:24796-24804.
42. Davis, R.J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553-14556.
43. Chen, R.H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol. Cell. Biol. 12:915-927.
44. Lenormand, P., C. Sardet, G. Pages, G. L'Allemain, A. Brunet, and J. Pouyssegur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell. Biol. 122:1079-1088.
45. Fukuda, M., Y. Gotoh, and E. Nishida. 1997. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO Eur. Mol. Bio. Organ.) J. 16:1901-1908.
46. Burgering, B.M., A.M.M. de Vries-Smits, R.H. Medema, P.C. van Weeren, L.G. Tertoolen, and J.L. Bos. 1993. Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways. Mol. Cell. Biol. 13:7248-7256.
47. Buscher, D., R.A. Hipskind, S. Krautwald, T. Reimann, and M. Baccarini. 1995. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell. Biol. 15:466-475.
48. Reuter, C.W., A.D. Catling, T. Jelinek, and M.J. Weber. 1995. Biochemical analysis of MEK activation m NIH3T3 fibroblasts. Identification of B-Raf and other activators. J. Biol. Chem. 270:7644-7655.
49. Winston, B.W., C.C. Lange, A.M. Gardner, G.L. Johnson, and D.W. Riches. 1995. Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc. Natl. Acad. Sci. USA. 92:1614-1618.
50. Chen, Q., T.H. Lin, C.J. Der, and R.L. Juliano. 1996. Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras. J Biol Chem. 271:18122-18127.
51. Cowen, D.S., R.S. Sowers, and D.R. Manning. 1996. Activation of a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptamine 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J. Biol. Chem. 271:22297-22300.
52. Gulbins, E., B. Brenner, K. Schlottmann, U. Koppenhoefer, O. Linderkamp, K.M. Coggeshall, and F. Lang. 1996. Activation of the Ras signaling pathway by the CD40 receptor. J. Immunol. 157:2844-2850.
53. Zheng, C.F., and K.L. Guan. 1993. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J. Biol. Chem. 268:23933-23939.
54. Jelinek, T., A.D. Catling, C.W. Reuter, S.A. Moodie, A. Wolfman, and M.J. Weber. 1994. RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell. Biol. 14:8212-8218.
55. Downey, G.P., J.R. Butler, J. Brumell, N. Borregaard, L. Kjeldsen, A. Sue, A.K. Quan, and S. Grinstein. 1996. Chemotactic peptide-induced activation of MEK-2, the predominant isoform in human neutrophils. Inhibition by wortmannin. J. Biol. Chem. 271:210015-21011.
56. Winston, B.W., L.K. Remigio, and D.W. Riches. 1995. Preferential involvement of MEK1 in the tumor necrosis factor-alpha-induced activation of p42mapk/erk2 in mouse macrophages. J. Biol. Chem. 270:27391-27394.
57. Alessi, D.R., N. Gomez, G. Moorhead, T. Lewis, S.M. Keyse, and P. Cohen. 1995. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5:283-293.
58. Xu, S., D. Robbins, J. Frost, A. Dang, C.C. Lange, and M.H. Cobb. 1995. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 92:6808-6812.
59. Bokemeyer, D., A. Sorokin, M. Yan, N.G. Ahn, D.J. Templeton, and M.J. Dunn. 1996. Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J. Biol. Chem. 271:639-642.
60. Groom, L.A., A.A. Sneddon, D.R. Alessi, S. Dowd, and S.M. Keyse. 1996. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO (Eur. Mol. Biol. Organ.) J. 15:3621-3632.